Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target ...

Moderna is due to report its second-quarter financial results on Friday ahead of the market open, a day after announcing ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Alnylam stock jumps after Q2 earnings beat and higher 2025 guidance, led by Amvuttra's rapid uptake and strong growth across ...

Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.07 per share a year ago. These ...

A rally in big tech drove stocks toward fresh all-time highs on the eve of a key jobs report that’s forecast to show moderation in hiring, and help make the case for the Federal Reserve to cut ...

A rally in big tech drove stocks higher, with the market holding gains after the latest inflation and spending data ...